The company is developing programs targeting cancer stem cells, including a lead compound for Acute Myeloid Leukemia, and is in the process of raising funds for that purpose The presentation is in Barcelona, Spain on November 18-21 Marseille, France, October 1, 2014 - Genoscience Pharma, a company focused on discovering and developing small molecules to treat cancer by targeting cancer stem cells, today announces that it will present data on its most promising candidate at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, in Barcelona, Spain, on November 18-21, 2014.
http://ift.tt/1rM3iGn
http://ift.tt/1rM3iGn
No comments:
Post a Comment